1. Home
  2. RGEN vs EPAM Comparison

RGEN vs EPAM Comparison

Compare RGEN & EPAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • EPAM
  • Stock Information
  • Founded
  • RGEN 1981
  • EPAM 1993
  • Country
  • RGEN United States
  • EPAM United States
  • Employees
  • RGEN N/A
  • EPAM N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • EPAM EDP Services
  • Sector
  • RGEN Health Care
  • EPAM Technology
  • Exchange
  • RGEN Nasdaq
  • EPAM Nasdaq
  • Market Cap
  • RGEN 8.0B
  • EPAM 8.2B
  • IPO Year
  • RGEN N/A
  • EPAM 2012
  • Fundamental
  • Price
  • RGEN $123.26
  • EPAM $184.66
  • Analyst Decision
  • RGEN Buy
  • EPAM Buy
  • Analyst Count
  • RGEN 12
  • EPAM 16
  • Target Price
  • RGEN $172.67
  • EPAM $229.00
  • AVG Volume (30 Days)
  • RGEN 793.9K
  • EPAM 735.5K
  • Earning Date
  • RGEN 04-29-2025
  • EPAM 05-08-2025
  • Dividend Yield
  • RGEN N/A
  • EPAM N/A
  • EPS Growth
  • RGEN N/A
  • EPAM N/A
  • EPS
  • RGEN N/A
  • EPAM 7.15
  • Revenue
  • RGEN $650,429,000.00
  • EPAM $4,864,167,000.00
  • Revenue This Year
  • RGEN $13.93
  • EPAM $14.70
  • Revenue Next Year
  • RGEN $14.35
  • EPAM $7.82
  • P/E Ratio
  • RGEN N/A
  • EPAM $25.83
  • Revenue Growth
  • RGEN 4.88
  • EPAM 4.72
  • 52 Week Low
  • RGEN $102.97
  • EPAM $138.15
  • 52 Week High
  • RGEN $182.52
  • EPAM $269.00
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 41.34
  • EPAM 66.25
  • Support Level
  • RGEN $123.10
  • EPAM $156.21
  • Resistance Level
  • RGEN $135.47
  • EPAM $189.62
  • Average True Range (ATR)
  • RGEN 7.10
  • EPAM 4.51
  • MACD
  • RGEN -1.05
  • EPAM 4.15
  • Stochastic Oscillator
  • RGEN 5.39
  • EPAM 86.29

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About EPAM EPAM Systems Inc.

EPAM Systems is a global IT services firm that offers platform engineering, software development, and consulting services. EPAM's largest market is North America, which represents approximately 60% of revenue. Offerings span assisting companies with new technologies, such as artificial intelligence, virtual reality, and robotics.

Share on Social Networks: